Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. NVDA
6. ROIV
7. CRCL
8. V
9. HOOD
10. XOM

Go back to Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
(NASDAQ: ALLR) Delayed: 1.35 -0.07 (4.93%)
Previous Close $1.42    52 Week High $ 
Open $1.36    52 Week Low $ 
Day High $1.36    P/E N/A 
Day Low $1.35    EPS $ 
Volume 16,293       

(NASDAQ: ALLR) Delayed: 1.35 -0.07 (4.93%)
Previous Close $1.42    52 Week High $ 
Open $1.36    52 Week Low $ 
Day High $1.36    P/E N/A 
Day Low $1.35    EPS $ 
Volume 16,293